The Charles Schwab Corporation
The Charles Schwab Corporation (SCHW) Financial Performance & Income Statement Overview
Analyze The Charles Schwab Corporation (SCHW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
The Charles Schwab Corporation (SCHW) Income Statement & Financial Overview
Review The Charles Schwab Corporation SCHW income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $6.65B | $6.65B | $6.55B | $6.35B |
| Cost of Revenue | $1.05B | $1.39B | $1.71B | $1.66B |
| Gross Profit | $5.41B | $5.33B | $4.85B | $4.69B |
| Gross Profit Ratio | $0.81 | $0.80 | $0.74 | $0.74 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.77B | $1.63B | $1.62B | $1.56B |
| Operating Expenses | $3.14B | $3.02B | $3.005B | $2.94B |
| Total Costs & Expenses | $3.47B | $4.35B | $4.71B | $4.60B |
| Interest Income | $3.76B | $3.85B | $3.93B | $3.82B |
| Interest Expense | $1.05B | $1.32B | $1.71B | $1.66B |
| Depreciation & Amortization | $347.00M | $354.00M | $361.00M | $362.00M |
| EBITDA | $2.80B | $2.66B | $2.20B | $2.11B |
| EBITDA Ratio | $0.42 | $0.40 | $0.34 | $0.33 |
| Operating Income | $2.46B | $2.31B | $1.84B | $1.75B |
| Operating Income Ratio | $0.37 | $0.35 | $0.28 | $0.28 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $2.46B | $2.31B | $1.84B | $1.75B |
| Income Before Tax Ratio | $0.37 | $0.35 | $0.28 | $0.28 |
| Income Tax Expense | $546.00M | $465.00M | $434.00M | $415.00M |
| Net Income | $1.91B | $1.84B | $1.41B | $1.33B |
| Net Income Ratio | $0.29 | $0.28 | $0.21 | $0.21 |
| EPS | $0.99 | $0.94 | $0.71 | $0.66 |
| Diluted EPS | $0.99 | $0.94 | $0.71 | $0.66 |
| Weighted Avg Shares Outstanding | $1.82B | $1.83B | $1.83B | $1.83B |
| Weighted Avg Shares Outstanding (Diluted) | $1.82B | $1.84B | $1.83B | $1.83B |
The company's financials show resilient growth, with revenue advancing from $6.35B in Q2 2024 to $6.65B in Q1 2025. Gross profit remained healthy with margins at 81% in Q1 2025 compared to 74% in Q2 2024. Operating income hit $2.46B last quarter, sustaining a consistent 37% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.80B. Net income rose to $1.91B, while earnings per share reached $0.99. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan